Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Amidoxime-Based Near-Infrared Fluorescent Sensor for Highly Sensitive Uranium Detection in Living Systems.

Analytical chemistry·2026
Same author

The dual correlations between core beliefs changes and emotion regulation among disaster-affected residents: the moderating role of religiousness orientation.

Frontiers in psychology·2026
Same author

Microbial Degradation of Herbicide Residues in Australian Soil: An Overview of Mechanistic Insights and Recent Advancements.

Toxics·2025
Same author

Thermoelectric property regulation of dimer-triangulene molecular junctions based on oxygen edge-modification engineering.

Physical chemistry chemical physics : PCCP·2025
Same author

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Cell·2025
Same author

Enhancing carbonation resistance of alkali-activated fly ash-slag pastes: Role of albite and dolomite additives.

Environmental research·2025

相关实验视频

Updated: Sep 11, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.3K

基于自适应网络的微生物药物协会预测模型,结构拓信息与整合战略的融合.

Liugen Wang, Bai Zhang, Hanwen Wu

    IEEE transactions on computational biology and bioinformatics
    |August 14, 2025
    PubMed
    概括

    一个新的计算模型,ANFAISMDA,有效地识别了微生物与药物之间的关联,以对抗微生物耐药性. 这种方法有助于开发更好的治疗方法和监测耐药性模式.

    科学领域:

    • 计算生物学是一种计算生物学.
    • 微生物学 微生物学
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 微生物耐药性是一个关键的全球卫生问题.
    • 了解微生物与药物之间的关系是开发有效治疗方法和打击耐药性的关键.
    • 需要有效的计算方法来识别这些关联.

    研究的目的:

    • 提出ANFAISMDA,一种用于识别潜在的微生物药物关联的新型计算模型.
    • 提高预测微生物与药物相互作用的准确性和效率.
    • 支持优化抗微生物药物治疗和耐药性监测.

    主要方法:

    • 利用微生物16S rRNA基因序列和药物SMILES结构进行特征提取.
    • 采用对称矩阵完成算法来获得拓信息.
    • 开发了一种适应性网络融合算法,以整合结构和拓数据.
    • 实施了整合策略,以提高预测性能.

    主要成果:

    • 通过实验验证,ANFAISMDA证明了其可靠性和有效性.
    • 该模型成功地确定了潜在的微生物与药物的关联.
    • 可视化显示了前50个微生物药物协会中的有趣模式.

    更多相关视频

    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
    07:39

    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

    Published on: April 6, 2021

    3.5K
    Constructing and Visualizing Models using Mime-based Machine-learning Framework
    06:19

    Constructing and Visualizing Models using Mime-based Machine-learning Framework

    Published on: July 22, 2025

    652

    相关实验视频

    Last Updated: Sep 11, 2025

    Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
    13:18

    Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

    Published on: March 3, 2023

    1.3K
    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
    07:39

    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

    Published on: April 6, 2021

    3.5K
    Constructing and Visualizing Models using Mime-based Machine-learning Framework
    06:19

    Constructing and Visualizing Models using Mime-based Machine-learning Framework

    Published on: July 22, 2025

    652

    结论:

    • ANFAISMDA模型是优化抗菌药物治疗和监测耐药性的宝贵工具.
    • 该方法有助于更深入地了解微生物与药物相互作用机制.
    • 这项研究解决了细菌耐药性带来的重大挑战.